Shows / Rx for Biotech
Rx for Biotech
"Rx for Biotech" is a healthcare education podcast dedicated to helping patients, caregivers, and healthcare professionals understand the rapidly evolving world of advanced therapies - and how patients can access them. From cell therapies and gene therapies to radiopharmaceuticals, immunotherapies, and next-generation treatments for cancer and autoimmune disease, this channel bridges the gap between breakthrough science and real-world patient care. Hosted by Chris Leidli, founder of Genoplex…
Episodes
Rx for BiotechCan Alpha Radiation Destroy Cancer? The Future of Targeted Cancer Therapy | Orano Med
What if we could deliver powerful radiation directly to cancer cells while limiting damage to surrounding healthy tissue? A new generation of cancer treatments…
Rx for BiotechFrom the CIA to Agentic AI: Bennett Borden on AI Adoption in Healthcare
AI is no longer just writing emails, summarizing documents, or answering questions. The rise of agentic AI is transforming how organizations make decisions…
Rx for BiotechWhat If It’s Not Just Stress? Hormones, Menopause & Women’s Health with Sharon Lemoine, ARNP
What if your fatigue, anxiety, weight gain, poor sleep, low libido, or brain fog are not “just stress”? Too many women are told they are stressed, anxious…
Rx for BiotechHow Cancer Uses an “Invisibility Cloak” - And How Kazia Therapeutics Is Trying to Remove It
We all know that cancer is caused by the rapid growth of tumor cells - but the ability for cancer to hide from the immune system is also a big challenge that…
Rx for BiotechSynthetic Lethality Explained: Targeting Cancer’s DNA Repair Weaknesses
Can precision oncology help identify cancer’s genetic weaknesses and turn them into therapeutic opportunities? In this episode of "Rx for Biotech", host Chris…
Rx for BiotechCan T-Cell Engagers Crack Solid Tumors? The Next Frontier in Cancer Immunotherapy
Can we teach the immune system to attack solid tumors more effectively - and potentially create longer-lasting responses for cancer patients? In this episode…
Rx for BiotechYour Doctor Might Have Missed It - How AI Is Giving Cancer Patients a Second Opinion
Can artificial intelligence help cancer patients understand their diagnosis, find more personalized treatment options, and become better advocates for their…
Rx for BiotechCan Stem Cell Therapy Heal Chronic Back Pain? The Future of Regenerative Medicine
Can stem cell therapy help repair damaged spinal discs instead of simply masking pain? Millions of people suffer from chronic low back pain and degenerative…
Rx for BiotechPart 2: What Is Radioligand Therapy? A New Precision Treatment for Cancer Explained
What if cancer treatment could find and destroy cancer cells with extraordinary precision while minimizing damage to healthy tissue? In Part 2 of this special…
Rx for BiotechPart 1: The Radiopharmaceutical Launch Playbook: What Pharma Must Get Right Beyond the Drug
What does it really take to successfully launch a radiopharmaceutical? In Part 1 of this special roundtable “Rx for Biotech” podcast series, Chris Leidli met…
Rx for BiotechWhy Fertility Care Needs to Change - And How Technology Can Help
What if AI could help women better understand their bodies and take control of their health before problems become crises? In this episode of #RxforBiotech…
Rx for BiotechThe Future of Multiple Sclerosis Treatment: New Hope for MS Patients | Jason Tardio, Immunic
What if the future of multiple sclerosis treatment could go beyond suppressing inflammation - and actually help protect the brain? In this episode of Rx for…
Rx for BiotechWhat If Your Own Cells Could Cure Cancer? CAR-T Therapy Explained
What if your own immune cells could be engineered to fight and even cure cancer? In this episode of Rx for Biotech, host Chris Leidli sits down with Navneet…
Rx for BiotechThe Future of Brain Cancer Care: Combining Diagnostics and Targeted Radiation Therapy
Why is brain cancer so hard to detect and treat - and what if we could change that? In this episode of Rx for Biotech, host Chris Leidli sits down with Marc…
Rx for BiotechHow Ossium Health is Changing Stem Cell Therapy and Regenerative Medicine
What if you could get a Transplant and Reset your Immune System in less than 48 Hours? In this episode of Rx for Biotech, host Chris Leidli sits down with…
Rx for BiotechHow Targeted Chemotherapy and Immunotherapy are Changing Cancer Care
What if chemotherapy could target tumors without harming the rest of the body? In this episode of *Rx for Biotech*, host Chris Leidli sits down with Christina…
Rx for BiotechThe Future of Precision Medicine: How Biomarkers Can Guide Your Treatment
What if a simple blood test could reveal how your body responds to disease - or even help doctors choose the right treatment for you? In this episode of Rx for…
Rx for BiotechHow Novartis is Changing Cancer Treatment and Putting Patients First in Modern Cancer Care
In this episode of "Rx for Biotech", host Chris Leidli speaks with Rodney Gillespie, Senior Vice President and U.S. Therapeutic Area Head for Oncology at…
Rx for BiotechFixing the Body's Shield: A New Way to Fight Neurodegenerative Diseases
What if helping the immune system find balance could meaningfully slow disease progression for diseases like ALS or Alzheimer’s? In this episode of Rx for…
Rx for BiotechHow to Advocate for Yourself in Cancer Care: Insights from a Top Oncologist
A cancer diagnosis can feel overwhelming - but patients are not powerless. In this episode, Dr. Nainesh Parikh of Moffitt Cancer Center explains how patients…
Rx for BiotechA New Hope for Skin Cancer: The Story Behind a Promising Immunotherapy
This episode is about hope, and about a different way of thinking about cancer treatment. My guest is Dr. Øystein Rekdal, CEO and co-founder of Lytix…
Rx for BiotechTargeting the Fire Within: How InflaRx Is Redefining Inflammation Control
InflaRx CEO Dr. Niels Riedmann joins Rx for Biotech to discuss how the company is pioneering complement-directed therapies to control severe inflammation and…
Rx for BiotechHow Novel Genetic Medicines may improve treatment of chronic Neurological Diseases
In this episode of Rx for Biotech podcast, I speak with Philippe Chambon MD, PhD, CEO of EG 427, about how his company's HERMES technology platform could…
Rx for BiotechRestoring Breath: Biologic Innovation for the Most Vulenerable Patients
Airway Therapeutics is taking on one of the toughest challenges in medicine - helping premature infants breathe on their own. In this episode of Rx for…
Rx for BiotechReprogramming Immunity: How CCR5 Blockade Could Redefine Cancer Therapy
In this podcast episode, Dr. Jay Lalezari, CEO of CytoDyn Therapeutics, discusses the company's progress in developing a novel immunotherapy that targets the…
Rx for BiotechThe Alpha Edge: Perspective Therapeutics on the Future of Theranostics and Radiopharmaceutical Therapies
In this episode of Tc for Biotech, host Chris Leidli sits down with Thijs Spoor, CEO of Perspective Therapeutics, to unpack the future of radiopharmaceuticals…
Rx for BiotechHarnessing the Immune System: PDS Biotech’s NextGen Approach to Cancer Treatment
In this episode of Rx for Biotech, host Chris Leidli sits down with Dr. Frank Bedu-Addo, CEO of PDS Biotechnology, to discuss how the company is reimagining…
Rx for BiotechHow Nonacus is Changing Cancer Detection with CEO, Jeff Bousfield
Early cancer detection doesn't have to mean invasive tests. In this podcast episode, we sit down with Jeff Bousfield, CEO of Nonacus Cancer Diagnostics, to…
Rx for BiotechHope in Hard Places: A Potential New Option for Patients with Pancreatic Cancer
Metastatic pancreatic cancer remains one of the deadliest cancers, but a new approach is taking shape - and it's showing promise in early clinical studies. In…
Rx for BiotechHow Mesenchymal Stem Cells Are Shaping the Future of Medicine with Dr. Kilian Kelly
In this podcast episode, Dr. Kilian Kelly, CEO of Cynata Therapeutics, discusses the future of regenerative medicine! Discover how mesenchymal stem cells…
Rx for BiotechPatient Perspective with CAR-T Cell Therapy Advocate, Brad Watt
Our guest in this podcast episode is lymphoma survivor and CAR-T cell therapy patient advocate, Brad Watts. In this episode, Brad shares his personal story…
Rx for BiotechHow AI is Transforming Job Search and Recruiting in Life Sciences and Technology
AI is transforming job search, recruiting and hiring practices. Our guest in this podcast episode is Steve Swan, Practice Leader at The Swan Group. Steve is an…
Rx for BiotechFrom Nigeria to the USA: Gene Therapy Journey with Sickle Cell Warrior, Jimi Olaghere
Gene therapy offers significant hope for treating sickle cell disease (SCD), a genetic disorder caused by a single mutation in the hemoglobin gene. Recent…
Rx for BiotechThe Promise of Dendritic Cell Vaccines with Diakonos Oncology President and COO Jay Hartenbach
In this podcast episode, hear from Diakonos Oncology President and Chief Operating Officer Jay Hartenbach, who provides an update on the company's innovative…
Rx for BiotechNew Therapies for Brain Cancer with Neurosurgeon Thomas Chen, CEO of NeOnc
Dr. Thomas Chen is a world-renowned neurosurgeon, Director of Surgical Neuro-Oncology at the University of Southern California, and the founder and CEO of…
Rx for BiotechFrom Meditation to Music: Exploring AI's Boundless Potential with Sreekanth Gopi
Our guest in this podcast episode is Sreekanth Gopi, a leader in generative AI and machine learning. Sreekanth has applied AI to fields as diverse as…
Rx for BiotechHow Arvinas is Transforming Cancer and Neuroscience Therapies: An Interview with CBO, Randy Teel, PhD
Arvinas is a biotech company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases. In this podcast episode…
Rx for BiotechThe Future of Healthcare: Insights from the Biggest Health Tech Conference of 2024
HLTH brings together all the ecosystem stakeholders each year to discuss the innovations that will help solve some of healthcare's biggest challenges. In this…
Rx for BiotechHow NGGT is Pioneering the Next Wave of Gene Therapies
Next Generation Gene Therapies is developing novel gene therapies for the treatment of many rare diseases. In this podcast episode, the company's Co-Founder…
Rx for BiotechUnlocking the Power of IL-2 with Aulos CEO, Aron Knickerbocker
Immunotherapies continue to redefine treatment for many types of cancer and one of the first immunotherapies approved and used clinically as a therapeutic is…
Rx for BiotechLeft Behind: Addressing Health Equity for the Rare Disease Patient Community
In this podcast episode, we discuss the importance of addressing health equity for the rare disease community with Tamar Thompson, Head of Corporate Affairs at…
Rx for BiotechEmerging Cell Therapies for Blood Cancers with Arcellx CMO, Chris Heery, MD
In this podcast episode, we sit down with Christopher Heery, the Chief Medical Officer at Arcellx to learn about the company's pipeline and lead cell therapy…
Rx for BiotechUnlocking AI In Oncology with James Zou, PhD
In this podcast episode, Dr. James Zou, Associate Professor of Biomedical Data Science and Faculty DIrector of the AI for Health department at Stanford…
Rx for BiotechRevolutioning Patient Access: An Interview with Genoplex CTO, Shoukri Kattan
In this episode, Genoplex Founder and CEO, Chris Leidli, and CTO, Shoukri Kattan, take a dive deep into their shared passion for health, wellness, and…
Rx for BiotechBuilding a Leading Cell Therapy Service Line with Robb Richards - Penn Medicine
Our guest for this podcast episode is Robb Richards, Corporate Director of Cell Therapy and Transplant at University of Pennsylvania, Penn Medicine. In this…
Rx for BiotechHow MedStack helps Health Tech companies with Compliance and Data Privacy
Our guest for this episode is Balaji Gopalan, CEO and Co-Founder of MedStack where we discuss how MedStack's tech stack is enabling digital health start-ups to…
Rx for BiotechHow NervGen is Developing Novel Treatments to Repair Damage to the Nervous System
Our guest for this podcast episode is Mike Kelly, President & CEO of NervGen Pharma. NervGen is a clinical-stage biotech company at the forefront of developing…
Rx for BiotechASCO 2024 Recap, ADCs, Cell Therapies and RLTs
In this podcast episode, your host, Chris Leidli, MS, MBA, goes beyond the ASCO 2024 headlines and puts a spotlight on the new clinical data for advanced…
Rx for BiotechASGCT 2024 Abstracts Preview
In this episode, we preview the top American Society of Gene and Cell Therapy (ASGCT) 2024 annual meeting abstracts with guests Dr. Emily Walsh Martin from…
Rx for BiotechUpdate on Evolving Tech and Data Standards to Improve Cell Therapy Informatics
Over the years, electronic health records (EHRs) have revolutionized medical practice, digitizing patient data and streamlining care. But the current systems…
Rx for BiotechHow Ryght is Building a Generative AI Platform for BioPharma
Our guest for this podcast episode is Simon Arkell, CEO of Ryght. Ryght is developing the next generation of safe and secure generative AI to empower Life…
Rx for BiotechRevolutionizing Genetic Counseling: A Conversation with Igentify CEO, Doron Behar
Our guest for this podcast episode is Doron Behar, MD, PhD, co-founder and CEO of Igentify, a digital health, artificial intelligence and genetic counseling…
Rx for BiotechASGCT Annual Meeting Preview
This episode features a preview of the American Society of Gene and Cell Therapy Annual Meeting scientific symposium on the impact of Generative AI on cell and…
Rx for Biotech2024 Biopharma Investment Outlook with Chris Dokomajilar
Our guest in this podcast episode is Chris Dokomajilar, Founder and CEO of DealForma. DealForma’s comprehensive life science database includes meticulously…
Rx for BiotechHow one Survivor beat the odds against Mucosal Melanoma
We often don’t get the chance to hear from survivors and patient advocates whose lives have been impacted by advanced medicines; so that makes this podcast…
Rx for BiotechMark Carbone on How Respiratory Muscle Training can improve Cardiopulmonary Outcomes
Our guest for this podcast episode is Mark Carbone, the CEO of PN Medical. PN Medical is a leader in respiratory care and research. The company created “The…
Rx for BiotechEpisode 2: Future Advances in Cell Therapy Analytics
In part 2 of this special round table podcast series, we discuss the future trends and advances in cell therapy manufacturing and the impact of AI on the…
Rx for BiotechEpisode 1: Current Advancements in Cell Therapy Analytics
In part 1 of this special round table podcast series, we discuss the current trends and advances in cell therapy manufacturing and the impact of evolving…
Rx for BiotechHealth Policy Update: IRA, 340b Drug Pricing and PBMs
Our guest for this podcast episode is Laura Hobbs, Director of Healthcare Policy at the American Action Forum. In this episode, we discuss the Inflation…
Rx for BiotechSpecial Episode: ASGCT Policy Summit Highlights
In this special episode, listen to Emily Walsh Martin, PhD, Principal at Tremont Therapeutics Consulting, as she shares some of the key highlights from the…